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23 patients (53.4%; 95% CI 38.6%-68.4%). This result is consistent with two prior studies
of PEA utilizing transesophageal echocardiography. CONCLUSION: The 2 MHz audible
Doppler provides rapid, accurate and non-invasive evidence of cardiac contractility and
thus occult blood flow in a substantial proportion of cardiac arrest patients with suspected
PEA. Developing a "Suspected PEA With Occult Blood Flow" algorithm may lead to more
appropriate treatment and improved survival.
1154-94 Effects of Incomplete Chest Wall Decompression During 
Cardiopulmonary Resuscitation on Coronary and 
Cerebral Perfusion Pressures in a Porcine Model of 
Cardiac Arrest
Demetris Yannopoulos, Gardar Sigurdsson, Scott McKnite, David Benditt, Tom 
Aufderheide, Ron Pirrallo, Terry Prove, Todd Zielinski, Keith G. Lurie, University of 
Minnesota, Minneapolis, MN, Medical College of Wisconsin, Madisson, WI
BACKGROUND: Recent data suggest that generation of negative intra-thoracic pressure
during the decompression phase of CPR improves hemodynamics, organ perfusion and
survival. We hypothesize that incomplete chest wall recoil during the decompression
phase of standard CPR increases intrathoracic pressures and intracranial pressures
resulting in a decrease in venous return in the chest cavity and therefore a decrease in
coronary perfusion pressure, an increase in intracranial pressure and a decrease in cere-
bral perfusion pressures.
METHODS: 9 pigs in ventricular fibrillation for 6 min, were treated with an automated
compression/decompression device with compressions at 100/min and a depth of 25% of
the antero-postero diameter and a compression to ventilation ratio of 15:2 with 100%
decompression (standard CPR) for 3 min. Compression depth was reduced to 75% of
complete decompression for 1 min of CPR and then restored for another 1 min of CPR to
100% decompression. Coronary perfusion pressure (CPP) was calculated as the dias-
tolic (aortic – right atrial (RA) pressure). Cerebral perfusion pressure (CePP) was calcu-
lated as diastolic (Aortic minus intracranial pressure). Unpaired t-test was used for
statistical analysis. All pressures expressed as mmHg.
Results: With 100% - 75% - 100% chest wall recoil, the CPP was 23.5 ± 2.0, 15.0±1,
15.5±1 (P<0.01); CePP was 8.5±3.4,-0.9 ±2.4, 1.9±3 (P=0.03); diastolic aortic pressure
was 26.5±2.5, 19.3±2, 18.5±1.9; intracranial pressure during decompression was 18.1±
2.4, 20.2±2, 16.6± 2.3; RA diastolic pressure 3±1.8, 4.2±1.7, 3.17±1.4; and MAP was
41.6±3.3, 34.2±2.7, 38.6±2.9.
CONCLUSIONS: Incomplete chest wall recoil during the decompression phase of CPR
significantly decreased coronary and cerebral perfusion pressures and increased intrac-
ranial pressures.
1154-95 Chest Compression Device Improves Blood Flow in 
Cerebrum and Myocardium Achieving Neurologically 
Intact Survival in a Porcine Model of Prolonged Cardiac 
Arrest
Fumiaki Ikeno, Jennifer Lyons, Hideaki Kaneda, Yoichiro Hongo, Sascha Emami, 
Christine Nolasco, Mehrdad Rezaee, Stanford University, Palo Alto, CA
Background-The insufficient blood flow to the heart and brain generated by chest com-
pression affects survival after sudden death. In order to improve blood flow, an auto-
mated, self-adjusting, electromechanical device (AutoPulse) that utilizes a load-
distributing band to compress the anterior chest has been developed. In this study, blood
flow generated by CPR with AutoPulse (A-CPR) was compared to conventional CPR (C-
CPR) and the impact on neurological intact survival after prolonged cardiac arrest was
determined.
Methods and Results-8 minutes after induction of untreated ventricular fibrillation, 32 pigs
were randomized to either A-CPR (n=22) or C-CPR (n=10) for 4 minutes, followed by
resuscitation protocol with ventilation, defibrillation, and intravenous epinephrine.
Regional blood flows in heart and cerebrum were determined using neutron-activated
microspheres. A-CPR improved regional myocardial flow by 58 fold and cerebral flow by
13 fold as compared to C-CPR. 16/22 in A-CPR regained spontaneous circulation and
survived; 14/16 had normal cerebral performance category (CPC=1) at 24 hours (2/16
exhibited mild neurological dysfunction, CPC=2). None of the C-CPR subjects returned
to spontaneous circulation.
Conclusion-Improved hemodynamics with the AutoPulse CPR results in neurologically
intact survival in this model of prolonged cardiac arrest.
1154-96 A New Method for Detecting Cardiogenic Pulmonary 
Edema Before the Appearance of Clinical Signs and for 
the Evaluation of Treatment Efficacy
Michael Shochat, Simcha Meizel, Pavel Rabinivich, Benny Peled, Avraham Shotan, Hillel 
Jaffe, Hadera, Israel
The aim of this study was to investigate whether patients with heart disease can be effec-
tively monitored by a new index, ITI (internal thoracic impedance), so that evolving car-
diogenic pulmonary edema (CPE) can be detected at its pre-clinical stage. If reliable,
such monitoring could enable the early treatment of CPE, enhance its efficacy, and pos-
sibly abort the process of worsening pulmonary congestion. A new impedance monitor
(RS-205) was used in this study. This monitor measures ITI by subtracting the skin-elec-
trode contact impedance from total transthoracic impedance. The clinical onset of CPE
was determined according to accepted clinical and radiographic criteria. ITI of the right
side of the chest was measured every 30 minutes in 264 consecutive patients hospital-
ized for an acute coronary syndrome. In all 264 patients that comprised study population
monitoring was initiated when clinical symptoms and signs of CPE were absent. 38 of
these patients developed CPE during monitoring. In all 38 patients, ITI decreased by
more than 12% from the initial value 30 minutes and in 23 of these patients it occurred
one hour before the clinical onset of CPE, respectively (p<0.001). In light of these find-
ings therapy was initiated in 4 patients when an ITI decrease of 11-12% from initial value
was recorded. In these 4 patients, clinical CPE did not develop and ITI returned to initial
value after treatment. In contrast, ITI did not decrease by more than 10% in any of the
remaining 222 patients who did not develop CPE. Further evaluation of the impact of ITI
monitoring on the clinical course of patients at risk to develop CPE seems warranted.
Conclusion: TI monitoring was found to be an accurate, practical and reliable method to
detect CPE at its pre-clinical stage and to gauge of the effectiveness of the treatment.
The preliminary data in four patients show that treatment of CPE in its pre-clinical stage
may abort CPE evolution.
1154-97 Electrocardiogram Morphology Predictors of 
Pharmacologic Termination of Ventricular Tachycardia
John C. Somberg, Charles I. Haffajee, Sandor Timar, Steven J. Bailin, Istvan Sarosi, 
Walter P. Paladino, Ferenc Lakatos, Nicholas Z. Kerin, Jeno Tarjan, Jozsef Borbola, 
Janos Molnar, and The Amio-Aqueous Investigators, Rush University, Chicago, IL
Background: Pharmacologic termination of ventricular tachycardia (VT) is variable with
different degrees of efficacy with different agents. This study was undertaken to deter-
mine if there are morphologic characteristics of VT that may predict drug efficacy.
Methods: 172 patients with sustained VT were randomized to receive either a 150 mg
bolus of a new formulation of intravenous amiodarone (A) or a bolus of 100 mg lidocaine
(L). If the first bolus failed to terminate the VT, a second bolus was administered. If the VT
persisted, electroshock was delivered. In each patient, an electrocardiogram (EKG) was
recorded before drug administration during VT and was analyzed for VT morphology:
polymorphic vs monomorphic VT, QRS width, QRS amplitude, as well as ventricular rate.
Multivariate analysis (ANOVA) was performed to assess the possible predictors of VT ter-
mination.
Results: Of the 172 patients, 29 had shock resistant VT, 143 had sustained hemody-
namically unstable VT. Of the 94 patients who received A, 85 had monomorphic VT with
50 terminating pharmacologically (59%) and 9 had polymorphic VT with a 33% termina-
tion (NS). Of the 78 patient who received L, 74 had monomorphic VT with 44 (59%) phar-
macologic VT termination and 4 had polymorphic VT with a 25% termination (p=0.05).
For shock resistant monomorphic VT, the cumulative VT termination was 75% with A vs.
33% with L (p<0.05) and for shock resistant polymorphic VT 83% with A vs. 0% with L
(p<0.05). The QRS was narrower in converters vs. non converters (141±27 ms vs.
175±54 ms, p<0.001). There was a trend of slower VT rate between converters vs. non
converters (175±31 vs. 182±35 beats/minute, NS), but there was no difference in VT
amplitude. In the 172 patients, the cumulative VT terminations (pharmacologic and elec-
troshock) for A vs. L were 91% vs. 85% in monomorphic VT (NS) and 89% vs. 25% in
polymorphic VT (p<0.01).
Conclusions: Amiodarone was more effective than L in converting VT in patients with
